Pfizer is reportedly seeking approval for a 4th dose of COVID-19 vaccines for seniors


Pfizer is expected to seek authorization for a fourth dose in its COVID-19 vaccine regimen for seniors, The Associated Press reported Tuesday.
The additional booster shot would go to Americans 65 and older, in an effort to provide additional protection to age groups that are more vulnerable to serious illness by the coronavirus.
Pfizer has not yet submitted its request to the Food and Drug Administration and the Centers for Disease Control, but CEO Albert Bourla said earlier this week he believes a fourth dose is necessary. "The protection that you are getting from the third [dose], it is good enough, actually quite good for hospitalizations and deaths," he told CBS's Face the Nation. "It's not that good against infections, but doesn't last very long. But we are just submitting those data to the FDA and then we will see what the experts also will say outside Pfizer."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Pfizer has rolled out COVID-19 vaccines and boosters with varying regimens for specific age groups. Most recently, it postponed its request for approval for a shot for kids under age 5, saying it wants to compare data between a two-dose and three-dose regimen.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Summer Meza has worked at The Week since 2018, serving as a staff writer, a news writer and currently the deputy editor. As a proud news generalist, she edits everything from political punditry and science news to personal finance advice and film reviews. Summer has previously written for Newsweek and the Seattle Post-Intelligencer, covering national politics, transportation and the cannabis industry.
-
Should Britain withdraw from the European Convention on Human Rights?
Talking Point With calls now coming from Labour grandees as well as Nigel Farage and the Tories, departure from the ECHR 'is starting to feel inevitable'
-
5 outspoken cartoons about Epstein survivors taking center stage
Cartoons Artists take on cover-ups, Trump surrounded, and more
-
Codeword: September 6, 2025
The Week's daily codeword puzzle
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC